文摘
Triplex-forming oligonucleotides (TFOs) have been shownto inhibit both transcription in vitroand the expression of target genes in cell culture by binding topolypurine/polypyrimidine sequences inseveral human gene promoters. The c-myc protooncogeneis overexpressed in a variety of human cancersand appears to play an important role in the proliferation of thesecells. In an attempt to assay the abilityof triplex-forming oligonucleotides to inhibit expression of a targetgene in vivo, we have developed acellular system involving transfection of a c-mycpromoter-driven luciferase reporter plasmid with triplex-forming oligonucleotides targeted to the human c-mycprotooncogene. To increase the stability of theTFO, we have used modified phosphorothioate oligonucleotides.Triplex formation with a modifiedphosphorothioate oligonucleotide occurs with approximately equalbinding affinity as that seen using aphosphodiester oligonucleotide. Phosphorothioate-modified TFOstargeted to c-myc inhibit transcriptionof the c-myc promoter in HeLa cells as demonstrated by adecrease in luciferase expression from a luciferasereporter gene construct. These results suggests that triplexformation may represent a gene-specific meansof inhibiting specific protooncogene expression.